Taiwan
· Delayed Price · Currency is TWD EirGenix Statistics
Total Valuation
EirGenix has a market cap or net worth of TWD 21.96 billion. The enterprise value is 17.74 billion.
| Market Cap | 21.96B |
| Enterprise Value | 17.74B |
Important Dates
The next estimated earnings date is Friday, March 21, 2025.
| Earnings Date | Mar 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
EirGenix has 306.25 million shares outstanding. The number of shares has increased by 0.48% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 306.25M |
| Shares Change (YoY) | +0.48% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 1.42% |
| Owned by Institutions (%) | 7.48% |
| Float | 195.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 18.74 |
| PB Ratio | 2.32 |
| P/TBV Ratio | 2.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -17.98 |
| EV / Sales | 15.15 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -13.32 |
Financial Position
The company has a current ratio of 10.39, with a Debt / Equity ratio of 0.10.
| Current Ratio | 10.39 |
| Quick Ratio | 9.11 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.68 |
| Interest Coverage | -147.40 |
Financial Efficiency
Return on equity (ROE) is -10.00% and return on invested capital (ROIC) is -6.51%.
| Return on Equity (ROE) | -10.00% |
| Return on Assets (ROA) | -6.23% |
| Return on Capital (ROIC) | -6.51% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.11 |
| Inventory Turnover | 1.19 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.98% in the last 52 weeks. The beta is 0.61, so EirGenix's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | -27.98% |
| 50-Day Moving Average | 86.85 |
| 200-Day Moving Average | 85.73 |
| Relative Strength Index (RSI) | 31.54 |
| Average Volume (20 Days) | 1,960,041 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EirGenix had revenue of TWD 1.17 billion and -986.69 million in losses. Loss per share was -3.22.
| Revenue | 1.17B |
| Gross Profit | 279.34M |
| Operating Income | -1.10B |
| Pretax Income | -984.97M |
| Net Income | -986.69M |
| EBITDA | -817.30M |
| EBIT | -1.10B |
| Loss Per Share | -3.22 |
Balance Sheet
The company has 5.12 billion in cash and 907.13 million in debt, giving a net cash position of 4.22 billion or 13.77 per share.
| Cash & Cash Equivalents | 5.12B |
| Total Debt | 907.13M |
| Net Cash | 4.22B |
| Net Cash Per Share | 13.77 |
| Equity (Book Value) | 9.43B |
| Book Value Per Share | 30.84 |
| Working Capital | 5.72B |
Cash Flow
In the last 12 months, operating cash flow was -481.13 million and capital expenditures -850.89 million, giving a free cash flow of -1.33 billion.
| Operating Cash Flow | -481.13M |
| Capital Expenditures | -850.89M |
| Free Cash Flow | -1.33B |
| FCF Per Share | -4.35 |
Margins
Gross margin is 23.86%, with operating and profit margins of -93.87% and -84.27%.
| Gross Margin | 23.86% |
| Operating Margin | -93.87% |
| Pretax Margin | -84.12% |
| Profit Margin | -84.27% |
| EBITDA Margin | -69.80% |
| EBIT Margin | -93.87% |
| FCF Margin | n/a |
Dividends & Yields
EirGenix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.48% |
| Shareholder Yield | -0.48% |
| Earnings Yield | -4.50% |
| FCF Yield | -6.07% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EirGenix has an Altman Z-Score of 12.75.
| Altman Z-Score | 12.75 |
| Piotroski F-Score | n/a |